These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12385921)

  • 1. Saw palmetto alters nuclear measurements reflecting DNA content in men with symptomatic BPH: evidence for a possible molecular mechanism.
    Veltri RW; Marks LS; Miller MC; Bales WD; Fan J; Macairan ML; Epstein JI; Partin AW
    Urology; 2002 Oct; 60(4):617-22. PubMed ID: 12385921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue effects of saw palmetto and finasteride: use of biopsy cores for in situ quantification of prostatic androgens.
    Marks LS; Hess DL; Dorey FJ; Luz Macairan M; Cruz Santos PB; Tyler VE
    Urology; 2001 May; 57(5):999-1005. PubMed ID: 11337315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia.
    Marks LS; Partin AW; Epstein JI; Tyler VE; Simon I; Macairan ML; Chan TL; Dorey FJ; Garris JB; Veltri RW; Santos PB; Stonebrook KA; deKernion JB
    J Urol; 2000 May; 163(5):1451-6. PubMed ID: 10751856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saw palmetto for benign prostatic hyperplasia.
    Bent S; Kane C; Shinohara K; Neuhaus J; Hudes ES; Goldberg H; Avins AL
    N Engl J Med; 2006 Feb; 354(6):557-66. PubMed ID: 16467543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of increasing doses of saw palmetto fruit extract on serum prostate specific antigen: analysis of the CAMUS randomized trial.
    Andriole GL; McCullum-Hill C; Sandhu GS; Crawford ED; Barry MJ; Cantor A;
    J Urol; 2013 Feb; 189(2):486-92. PubMed ID: 23253958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benign prostatic hyperplasia treated with saw palmetto: a literature search and an experimental case study.
    McPartland JM; Pruitt PL
    J Am Osteopath Assoc; 2000 Feb; 100(2):89-96. PubMed ID: 10732392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saw palmetto for the treatment of men with lower urinary tract symptoms.
    Gerber GS
    J Urol; 2000 May; 163(5):1408-12. PubMed ID: 10751846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saw palmetto and benign prostatic hyperplasia.
    Gong EM; Gerber GS
    Am J Chin Med; 2004; 32(3):331-8. PubMed ID: 15344416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serenoa repens for benign prostatic hyperplasia.
    Wilt T; Ishani A; Mac Donald R
    Cochrane Database Syst Rev; 2002; (3):CD001423. PubMed ID: 12137626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of D-004, a lipid extract from the Cuban royal palm fruit, on atypical prostate hyperplasia induced by phenylephrine in rats.
    Arruzazabala ML; Más R; Molina V; Noa M; Carbajal D; Mendoza N
    Drugs R D; 2006; 7(4):233-41. PubMed ID: 16784248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms.
    Gerber GS; Kuznetsov D; Johnson BC; Burstein JD
    Urology; 2001 Dec; 58(6):960-4; discussion 964-5. PubMed ID: 11744467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double blind, placebo-controlled randomized comparative study on the efficacy of phytosterol-enriched and conventional saw palmetto oil in mitigating benign prostate hyperplasia and androgen deficiency.
    Sudeep HV; Thomas JV; Shyamprasad K
    BMC Urol; 2020 Jul; 20(1):86. PubMed ID: 32620155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phytotherapy for benign prostatic hyperplasia.
    Gerber GS
    Curr Urol Rep; 2002 Aug; 3(4):285-91. PubMed ID: 12149159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serenoa repens (Permixon): a 5alpha-reductase types I and II inhibitor-new evidence in a coculture model of BPH.
    Bayne CW; Donnelly F; Ross M; Habib FK
    Prostate; 1999 Sep; 40(4):232-41. PubMed ID: 10420151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serenoa repens extract for benign prostate hyperplasia: a randomized controlled trial.
    Willetts KE; Clements MS; Champion S; Ehsman S; Eden JA
    BJU Int; 2003 Aug; 92(3):267-70. PubMed ID: 12887481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study.
    Debruyne F; Koch G; Boyle P; Da Silva FC; Gillenwater JG; Hamdy FC; Perrin P; Teillac P; Vela-Navarrete R; Raynaud JP
    Eur Urol; 2002 May; 41(5):497-506; discussion 506-7. PubMed ID: 12074791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia.
    Plosker GL; Brogden RN
    Drugs Aging; 1996 Nov; 9(5):379-95. PubMed ID: 8922564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saw palmetto for prostate disorders.
    Gordon AE; Shaughnessy AF
    Am Fam Physician; 2003 Mar; 67(6):1281-3. PubMed ID: 12674456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia.
    Di Silverio F; Monti S; Sciarra A; Varasano PA; Martini C; Lanzara S; D'Eramo G; Di Nicola S; Toscano V
    Prostate; 1998 Oct; 37(2):77-83. PubMed ID: 9759701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial.
    Barry MJ; Meleth S; Lee JY; Kreder KJ; Avins AL; Nickel JC; Roehrborn CG; Crawford ED; Foster HE; Kaplan SA; McCullough A; Andriole GL; Naslund MJ; Williams OD; Kusek JW; Meyers CM; Betz JM; Cantor A; McVary KT;
    JAMA; 2011 Sep; 306(12):1344-51. PubMed ID: 21954478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.